The wound care management market comprises of dressings, equipment and other aids to prevent and treat wounds and quicken or promote wound healing. Traditional wound management involves the use of dressings which cover and protect the wound from infection. GlobalData uses proprietary data and analytics to provide a comprehensive report on the traditional wound management market in the US. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the traditional wound management market in the US was B. Braun Melsungen followed by BSN medical, Cardinal Health, Datt Mediproducts, Derma Sciences, Johnson & Johnson, Lohmann & Rauscher, Medline Industries, Molnlycke Health Care, Paul Hartmann and Smith & Nephew.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Traditional wound dressings are dry and do not provide a moist wound environment. They are used as primary or secondary dressings or from composites of several dressings with each performing a specific function. They serve as inert barriers to the wound. This segment includes gauzes, sponges, bandages, gauze sponges, and abdominal pads.

The traditional wound management market in the US can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size traditional wound management in the US, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.